Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase 4 1

Status

Completed 3Unknown 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1

Conditions

Prostatic Neoplasms 1Prostatic Intraepithelial Neoplasia 1Desmoid Tumors 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Toremifene × Clear all
NCT00020735 2015-12-02

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

University of Pittsburgh

Phase 2 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT00028353 2013-11-15

A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

GTx

Phase 2 Completed
500 enrolled
Genitourinary

Prostatic Intraepithelial Neoplasia

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡